NCT03690739 2022-02-24Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian CancerAGO Research GmbHPhase 3 Terminated9 enrolled
NCT02929394 2020-09-02Trabectedin Maintenance Post 1st-line in STSEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 3 Terminated13 enrolled